160 related articles for article (PubMed ID: 31621568)
1. Disease modification in osteoarthritis: are we there yet?
Oo WM; Hunter DJ
Clin Exp Rheumatol; 2019; 37 Suppl 120(5):135-140. PubMed ID: 31621568
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
Oo WM; Yu SP; Daniel MS; Hunter DJ
Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic therapy for osteoarthritis--the era of disease modification.
Hunter DJ
Nat Rev Rheumatol; 2011 Jan; 7(1):13-22. PubMed ID: 21079644
[TBL] [Abstract][Full Text] [Related]
4. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs.
Verbruggen G; Goemaere S; Veys EM
Clin Rheumatol; 2002 Jun; 21(3):231-43. PubMed ID: 12111630
[TBL] [Abstract][Full Text] [Related]
5. State-of-the-art disease-modifying osteoarthritis drugs.
Moskowitz RW; Hooper M
Curr Rheumatol Rep; 2005 Mar; 7(1):15-21. PubMed ID: 15760576
[TBL] [Abstract][Full Text] [Related]
6. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
Jotanovic Z; Mihelic R; Sestan B; Dembic Z
Curr Drug Targets; 2014 Jun; 15(6):635-61. PubMed ID: 24597569
[TBL] [Abstract][Full Text] [Related]
7. Prospects of Disease-Modifying Osteoarthritis Drugs.
Oo WM
Rheum Dis Clin North Am; 2024 Aug; 50(3):483-518. PubMed ID: 38942581
[TBL] [Abstract][Full Text] [Related]
8. Future therapeutics for osteoarthritis.
Martel-Pelletier J; Wildi LM; Pelletier JP
Bone; 2012 Aug; 51(2):297-311. PubMed ID: 22037003
[TBL] [Abstract][Full Text] [Related]
9. Anti-arthritic agents: progress and potential.
Laev SS; Salakhutdinov NF
Bioorg Med Chem; 2015 Jul; 23(13):3059-80. PubMed ID: 26014481
[TBL] [Abstract][Full Text] [Related]
10. Prospects for disease modification in osteoarthritis.
Abramson SB; Attur M; Yazici Y
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):304-12. PubMed ID: 16932709
[TBL] [Abstract][Full Text] [Related]
11. Current status and future prospects for disease modification in osteoarthritis.
Huang Z; Ding C; Li T; Yu SP
Rheumatology (Oxford); 2018 May; 57(suppl_4):iv108-iv123. PubMed ID: 29272498
[TBL] [Abstract][Full Text] [Related]
12. Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014.
Eckstein F; Le Graverand MP
Semin Arthritis Rheum; 2015 Dec; 45(3):251-6. PubMed ID: 26142321
[TBL] [Abstract][Full Text] [Related]
13. Development of a Disease-Modifying OA Drug (DMOAD) in Knee Osteoarthritis: The Example of Sprifermin.
Marhardt K; Muurahainen N
Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S13. PubMed ID: 26536178
[No Abstract] [Full Text] [Related]
14. How can one develop disease-modifying drugs in osteoarthritis?
Dougados M
Curr Rheumatol Rep; 2005 Mar; 7(1):22-8. PubMed ID: 15760577
[TBL] [Abstract][Full Text] [Related]
15. Current DMOAD options for the treatment of osteoarthritis.
Yeap SS
Clin Exp Rheumatol; 2020; 38(4):802. PubMed ID: 32141438
[No Abstract] [Full Text] [Related]
16. Current Treatment Options for Osteoarthritis.
Hermann W; Lambova S; Muller-Ladner U
Curr Rheumatol Rev; 2018; 14(2):108-116. PubMed ID: 28875826
[TBL] [Abstract][Full Text] [Related]
17. Imaging of OA - From disease modification to clinical utility.
Hayashi D; Roemer FW; Eckstein F; Samuels J; Guermazi A
Best Pract Res Clin Rheumatol; 2020 Dec; 34(6):101588. PubMed ID: 32943330
[TBL] [Abstract][Full Text] [Related]
18. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?
Qvist P; Bay-Jensen AC; Christiansen C; Dam EB; Pastoureau P; Karsdal MA
Pharmacol Res; 2008 Jul; 58(1):1-7. PubMed ID: 18590824
[TBL] [Abstract][Full Text] [Related]
19. Investigational drugs for the treatment of osteoarthritis, an update on recent developments.
Zhu Z; Li J; Ruan G; Wang G; Huang C; Ding C
Expert Opin Investig Drugs; 2018 Nov; 27(11):881-900. PubMed ID: 30345826
[TBL] [Abstract][Full Text] [Related]
20. Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities.
Blackburn WD
Am J Med; 1996 Feb; 100(2A):24S-30S. PubMed ID: 8604723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
